Jae‐Weon Kim

ORCID: 0000-0003-1835-9436 · 11 papers in corpus
2025
Journal of gynecologic oncology ·doi:10.3802/jgo.2025.36.e107

Informed consent is a fundamental aspect of surgical care, designed to reinforce patient autonomy, promote shared decision-making, and potentially mitigate legal conflicts by ensuring the provision of comprehensive and consistent informatio…

article 2021
Scientific reports ·doi:10.1038/s41598-021-87965-7

The preservation of ovarian reserve during laparoendoscopic single-site (LESS) ovarian cystectomy is crucial for reproductive-age women. This study was a single-blinded, single-center, and randomized controlled trial to evaluate the effect …

2019
Journal of gynecologic oncology ·doi:10.3802/jgo.2019.30.e91

The 34th Annual Meeting of Korean Society of Gynecologic Oncology (KSGO) was held in Busan, Korea from 26 to 27 April. Around 460 Korean and international clinicians gathered in Busan to share and discuss their latest work and key issues of…

2018
Journal of gynecologic oncology ·doi:10.3802/jgo.2018.29.e56

Since after 2006 when the first edition of practice guidelines for gynecologic oncologic cancer treatment was released, the Korean Society of Gynecologic Oncology (KSGO) has published the following editions on a regular basis to suggest the…

2017
Journal of gynecologic oncology ·doi:10.3802/jgo.2017.28.e45

In 2016, 13 topics were selected as major research advances in gynecologic oncology. For ovarian cancer, study results supporting previous ones regarding surgical preventive strategies were reported. There were several targeted agents that …

2017
Journal of gynecologic oncology ·doi:10.3802/jgo.2017.28.e54

There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and tr…

2016
Journal of gynecologic oncology ·doi:10.3802/jgo.2016.27.e36
article 2013
article 2013
article 2012
·doi:10.1016/j.ygyno.2012.12.037

ObjectiveTo analyze the outcomes of second round of fertility-sparing management using progestin in patients with recurrent endometrial cancer after successful fertility-sparing management using progestin.MethodsWe reviewed 45 patients who …

2005
Gynecologic Oncology ·doi:10.1016/j.ygyno.2005.01.043

BackgroundChoriocarcinoma of the fallopian tube is extremely rare as is choriocarcinoma with a viable pregnancy. We present an unusual case of prima gravida at 33 weeks gestation that was diagnosed as having tubal choriocarcinoma which was …